{"id":"NCT01337167","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)","officialTitle":"A Phase III Randomized, Open-Label, Active-Comparator Controlled Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V419 in Infants When Given at 2, 4, and 6 Months Concomitantly With Prevnar 13™ and RotaTeq™","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-04-19","primaryCompletion":"2013-05-09","completion":"2013-05-09","firstPosted":"2011-04-18","resultsPosted":"2016-03-16","lastUpdate":"2018-11-15"},"enrollment":1473,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Bacterial Infections","Virus Diseases"],"interventions":[{"type":"BIOLOGICAL","name":"V419","otherNames":[]},{"type":"BIOLOGICAL","name":"DAPTACEL™","otherNames":[]},{"type":"BIOLOGICAL","name":"PedvaxHIB™","otherNames":[]},{"type":"BIOLOGICAL","name":"Prevnar 13™","otherNames":[]},{"type":"BIOLOGICAL","name":"RotaTeq™","otherNames":["V260"]},{"type":"BIOLOGICAL","name":"PENTACEL™","otherNames":[]},{"type":"BIOLOGICAL","name":"Recombivax HB vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"ActHIB™","otherNames":[]}],"arms":[{"label":"V419","type":"EXPERIMENTAL"},{"label":"Control","type":"ACTIVE_COMPARATOR"}],"summary":"This is a study to assess the safety, tolerability, and immunogenicity of V419 (PR5I) when administered as an infant series at 2, 4, and 6 months of age followed by a toddler dose of DAPTACEL™, Prevnar 13™ and PedvaxHIB™ at 15 months of age. The study will determine whether subjects who receive V419 have a similar immune response to the vaccine compared to subjects who receive licensed component vaccine controls.","primaryOutcome":{"measure":"Percentage of Participants Responding to Polyribosylribitol Phosphate Antigen","timeFrame":"Postdose 3 (Month 7)","effectByArm":[{"arm":"V419","deltaMin":84.97,"sd":null},{"arm":"Control","deltaMin":75.39,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"46 Days","sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":6},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["26216331"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":58,"n":980},"commonTop":["Irritability","Injection-site pain","Crying","Somnolence","Injection-site erythema"]}}